EUVIMEDEUVIMED entdecken
Crossref

Vesicular Antibodies: Shedding Light on Antibody Therapeutics with Cell Membrane Nanotechnology

Chenchen Zhao, Yuanwei Pan, Guocan Yu, Xing-Zhong Zhao, Xiaoyuan Chen iD, Lang Rao

Advanced Materials · 2023-03 · 35 (12)

DOI: 10.1002/adma.202207875 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 31.01.2023. Verfasst von Chenchen Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China. Hauptthemen laut MEDLINE: Antibodies, Protein Engineering. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 126 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, National University of Singapore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The high stability of antibodies and their ability to precisely bind to antigens and endogenous immune receptors, as well as their susceptibility to protein engineering, enable antibody‐based therapeutics to be widely applied in cancer, inflammation, infection, and other disorders. Nevertheless, the application of traditional antibody‐based therapeutics has certain limitations, such as high price, limited permeability, and protein engineering complexity. Recent breakthroughs in cell membrane nanotechnology have deepened the understanding of the critical role of membrane protein receptors in disease treatment, enabling vesicular‐antibody‐based therapeutics. Here, the concept of vesicular antibodies that are obtained by modifying target antibodies onto cell membranes for biomedical applications is proposed. Given that an antibody is basically a protein, as an extension of this concept, vesicles or membrane‐coated nanoparticles that use surface antibodies and protein receptors on cell membranes for biomedical applications as vesicular antibodies are defined. Furthermore, several engineering strategies for vesicular antibodies are summarized and how vesicular antibodies can be used in a variety of situations is highlighted. In addition, current challenges and future prospects of vesicular antibodies are also discussed. It is anticipated this perspective will provide new insights on the development of next‐generation antibodies for enhanced therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntibodiesProtein EngineeringAntigensCell MembraneNanotechnology

Stichwörter der Autor:innen

antibodiesbiomaterialscell membranesnanoparticlesvesicles

Substanzen

AntibodiesAntigens

Autor:innen und Institutionen

  • Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen, 518132, China.
  • School of Physics and Technology, Wuhan University, Wuhan, 430072, China.
  • Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering, and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, S…
  • Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Tsinghua University, Beijing, 100084, China.
  • Centre for Translational Medicine, Clinical Imaging Research Centre, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.
  • Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.

ORCID-Profile: Xiaoyuan Chen

Förderung

  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • National University of Singapore
  • National Medical Research Council
  • Science and Technology Innovation Commission of Shenzhen
  • Shenzhen Bay Laboratory Open-Ended Fund

Zitieren

APA

Zhao, C., Pan, Y., Yu, G., Zhao, X. Z., Chen, X., & Rao, L. (2023). Vesicular Antibodies: Shedding Light on Antibody Therapeutics with Cell Membrane Nanotechnology. Advanced Materials, 35(12). https://doi.org/10.1002/adma.202207875

Vancouver

Zhao C, Pan Y, Yu G, Zhao XZ, Chen X, Rao L. Vesicular Antibodies: Shedding Light on Antibody Therapeutics with Cell Membrane Nanotechnology. Advanced Materials. 2023;35(12). doi:10.1002/adma.202207875

BibTeX
@article{Zhao2023,
  author = {Zhao, Chenchen and Pan, Yuanwei and Yu, Guocan and Zhao, Xing-Zhong and Chen, Xiaoyuan and Rao, Lang},
  title = {Vesicular Antibodies: Shedding Light on Antibody Therapeutics with Cell Membrane Nanotechnology},
  journal = {Advanced Materials},
  year = {2023},
  volume = {35},
  number = {12},
  doi = {10.1002/adma.202207875}
}
Kostenlos starten →